Laparoscopy for the Definitive Diagnosis of Intra-abdominal Lymphoma

Asoglu, Oktar; Porter, Lewis; Donohue, John H.; Cha, Stephan S.
May 2005
Mayo Clinic Proceedings;May2005, Vol. 80 Issue 5, p625
Academic Journal
OBJECTIVE: To assess the efficacy of laparoscopy In the diagnosis of intra-abdominal lymphoma. PATIENTS AND METHODS: The medical records of patients with suspected primary or recurrent lymphoma who underwent laparoscopy between March 1991 and March 2003 were reviewed. Demographic, clinical, operative, and pathologic data were collected. The feasibility, safety, and effectiveness of the laparoscopic procedure were assessed. RESULTS: Laparoscopic biopsy was attempted in 94 patients in 78 patients (83%), the procedure was completed laparoscopically. Conversion to laparotomy was undertaken in 16 patients (17%), most commonly because of inadequate exposure, insufficient tissue, or postoperative adhesions. Among the 69 cases of lymphoma, 55 (80%) were diagnosed via laparoscopy only, 9(13%) via laparotomy, and 5(7%) with later procedures. Of the remaining 25 patients, 7 had nonlymphoma disease (4 occult carcinomas, 1 multiple myeloma, 1 epithellold letomyosarcoma, and 1 neuroblastoma), and 18 had benign lymphadenopathy (no evidence of lymphoma with a mean follow-up of 53 months). The laparoscopic procedure resulted in false-negative results in 6 patients (6%). The mean hospital stay for patients having a laparotomy was 6 days (range, 3-10 days); the remaining patients were all outpatients. The only intraoperative laparoscopic complication was hemorrhage that required laparotomy. This event occurred in a patient with a previously undiagnosed neuroblastoma. CONCLUSION: Laparoscopic lymph node biopsy safely provides adequate tissue for full histological evaluation on an outpatient basis in most patients with intra-abdominal lymphoma.


Related Articles

  • Extirpation of mass-screened adrenal neuroblastomas by retroperitoneoscopy. Kouch, K.; Yoshida, H.; Matsunaga, T.; Ohtsuka, Y.; Okada, T.; Saito, T.; Matsuura, G.; Yamada, H.; Ohnuma, N. // Surgical Endoscopy;Nov2003, Vol. 17 Issue 11, p1769 

    Background: A mass-screened neuroblastoma (MSN) shows low-grade malignancy. Although the tumor is small, open laparotomy requires a large incision.Purpose: Extirpation by retroperitoneoscopy (ER) was performed in children with MSN to reduce the surgical...

  • Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR. Souzaki, Ryota; Tajiri, Tatsuro; Higashi, Mayumi; Kinoshita, Yoshiaki; Tanaka, Sakura; Kohashi, Kenichi; Tsuneyoshi, Masazumi; Taguchi, Tomoaki // Pediatric Surgery International;Oct2008, Vol. 24 Issue 10, p1095 

    Introduction: Recently, determining the MYCN status in neuroblastoma (NB) using the quantitative PCR (Q-PCR) and FISH instead of the Southern blotting (SB) has been recommended. In order to assess the implications of the gene dosage of MYCN in NB, the MYCN status was evaluated using...

  • Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing’s sarcoma. Cristina Zanini; Francesco Pulerà; Franco Carta; Giuliana Giribaldi; Giorgia Mandili; Milena Maule; Marco Forni; Franco Turrini // Virchows Archiv;Feb2008, Vol. 452 Issue 2, p157 

    Abstract  Neuroblastoma (NB) and Ewing’s sarcoma (ES) cell lines were analysed by two-dimensional gel electrophoresis (2-DE) searching for new diagnostic/prognostic markers. Protein expression profiles displayed a high degree of similarity with the exception of...

  • Olfactory neuroblastoma following treatment for pituitary adenoma. Kyung-Jae Park; Shin-Hyuk Kang; Hoon-Gab Lee; Yong-Gu Chung // Journal of Neuro-Oncology;Nov2008, Vol. 90 Issue 2, p237 

    Abstract  Olfactory neuroblastoma is extremely rare as a second neoplasm. We report an unusual case of olfactory neuroblastoma in a 59-year-old woman who had undergone two operations and received 54 Gy of irradiation for pituitary adenoma 20 years ago. At the time...

  • Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma? Wachowiak, Robin; Rawnaq, Tamina; Metzger, Roman; Quaas, Alexander; Fiegel, Henning; Kähler, Nils; Rolle, Udo; Izbicki, Jakob R.; Kaifi, Jussuf; Till, Holger; Kähler, Nils // Pediatric Surgery International;Dec2008, Vol. 24 Issue 12, p1361 

    Purpose: Neuroblastoma is a biological, genetic and morphological heterogeneous tumor with a variable clinical course. NCAM is a cell adhesion molecule belonging to the immunoglobulin superfamily with structural similarities to cell adhesion molecule L1. The aim of this study was to...

  • Madi ready to perform during Relay for Life. Young, Cherry // Graham Leader;5/31/2009, Vol. 133 Issue 83, p11A 

    The article offers information on the participation of Madisyn 'Madi' Meacham on the Relay for Life dance. It mentions that Madi plans to perform her very own hip hop routine for the crowd at the Relay for Life. It notes that Madi is soon-to-be 11 year-old cancer survivor and takes dance from...

  • Endocrine cancer in Iran: Based on cancer registry system. Haghpanah, V.; Soliemanpour, B.; Heshmat, R.; Mosavi-Jarrahi, A. R.; Tavangar, S. M.; Malekzadeh, R.; Larijani, B. // Indian Journal of Cancer;Apr-Jun2006, Vol. 43 Issue 2, p80 

    BACKGROUND: A population-based registry of endocrine cancer cases in four Iranian provinces, was performed for the years 1996-2000. MATERIALS AND METHODS: Patients in each province were grouped according to age, gender and tumor specifics (site, morphology, behavior) and the data was coded...

  • Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication. Wolf, Maija; Korja, Miikka; Karhu, Ritva; Edgren, Henrik; Kilpinen, Sami; Ojala, Kalle; Mousses, Spyro; Kallioniemi, Anne; Haapasalo, Hannu // BMC Cancer;2010, Vol. 10, p181 

    Background: Neuroblastoma has successfully served as a model system for the identification of neuroectodermderived oncogenes. However, in spite of various efforts, only a few clinically useful prognostic markers have been found. Here, we present a framework, which integrates DNA, RNA and tissue...

  • Neuropsychological resiliency after treatment for advanced stage neuroblastoma. Carpentieri, S. C.; Diller, L. R. // Bone Marrow Transplantation;Jun2005, Vol. 35 Issue 11, p1117 

    Summary:The purpose of this study was to describe the neuropsychological functioning of survivors of advanced stage neuroblastoma. In all, 16 survivors, diagnosed at a median of 2.8 years, who had received intensive chemotherapy and surgical treatments, were identified; 11 had received...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics